Upcoming GILD earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
October 28, 2026
Gilead Sciences is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Gilead reported a net loss of $10.5 billion in Q2 FY2026 due to $12.9 billion in one-time charges, overshadowing 10% revenue growth from HIV and oncology…
Gilead Sciences delivered a strong Q1 FY2026 with revenue up 4.4% to $6.96B, net income surging 53.7% to $2.02B, and operating cash flow jumping 44.8% to…
Gilead Sciences delivered a dramatic FY2025 turnaround, with net income surging 1,673% to $8.51B and operating margin expanding to 34% as prior-year charges…
Gilead Sciences (GILD) is scheduled to report earnings on October 28, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Gilead Sciences's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on August 6, 2026.
EarningsLens publishes free AI analysis of every GILD 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Gilead Sciences reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.